For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240827:nRSa6813Ba&default-theme=true
RNS Number : 6813B Headpoint Advisors 26 August 2024
Headpoint Advisors has advised the shareholders of online healthcare platform Oxford Online Pharmacy on securing a strategic investment from Rockpool
Headpoint has advised Oxford Online Pharmacy on its investment partnership
deal with Rockpool Investment LLP. The company is a fast-growing online
pharmacy offering accessible healthcare to patients' homes. The business has
evolved from its roots as a family-owned pharmacy chain established in 1925
into an online-focused healthcare platform.
The company provides cost-effective privately-prescribed medication and
healthcare advice to customers across the UK. The company is led by its
founder and CEO Stuart Gale and is supported by a highly-experienced and
dedicated management team. Rockpool will support Oxford Online Pharmacy to
accelerate its growth trajectory, further develop its technology
infrastructure and expand its leadership team. The strategic investment will
enhance the company's ability to meet the increasing demand for online
pharmacy services, particularly in the fast-growing weight loss sector.
(Stuart Gale, Founder and CEO, at Oxford Online Pharmacy)
Stuart Gale, Founder and CEO, at Oxford Online Pharmacy commented: "I am
delighted to partner with Rockpool to help us further grow the business.
Online healthcare is a fast-growing market and this investment will help us
expand the team, develop our technology platform and deliver our service to an
even wider customer base. Rockpool have been extremely supportive during the
process, and we are looking forward executing our strategic plan for the
business."
Darran Green, Partner at Rockpool Investments, said: "We are excited to
support Oxford Online Pharmacy as it continues to rapidly grow in the online
pharmacy sector. The company has an excellent reputation for innovation and a
strong commitment to patient care, while adhering to the highest clinical
standards. We look forward to working with Stuart and the management team to
further enhance this in the years ahead. Our investment reflects our
confidence in the company's vision, leadership, and commitment to
technology-enabled accessible healthcare".
Emmet Keating, Partner, Headpoint who led the deal commented: "We are very
pleased for the Oxford Online Pharmacy team to have completed this
transaction. Online pharmacy is rapidly disrupting the way that consumers
access healthcare treatments. The market is growing at c.20% per annum and
Oxford Online Pharmacy is one of the leaders in the UK, with over 20,000
positive Trustpilot reviews. The business is very well positioned to
capitalise on the market opportunity."
Emmet Keating was supported by Oliver Stephens and Henry Baker on corporate
finance aspects. Headpoint worked with Lodders Solicitors (Graham Spalding),
Parisi Tax (Lisa Stevenson) and PWC Tax (Nick Baker and Beth Cooper).
Rockpool (Darran Green, Oliver Taylor and Bethany Walls) were advised by
Bracher Rawlins (David Gerber, Rachel Atherton), Crowe UK (Robert Alsop, Jane
MacKay, Nick Brown, Jodie Green), Strategy& (Dr. John Gariba, Stephen
Aherne, Ashley Antonia Demirelli), Claritas Tax (Iain Wright), more2 (Chris
Simpson, Becky Jasper) Catalysis Advisory Ltd (Peter Fischer Brown) and
Palladium Digital (Ben Martin).
About Headpoint
Headpoint provides specialist corporate finance advice to owners of private
companies. Our clients include business founders, family owners / managers and
investors. We advise on company sales, acquisitions, management buy-outs,
business valuations and raising growth capital.
For more information, please call Mark Wilson on 0845 544 0500 or contact him
on email at
markwilson@headpointadvisors.com
To know more about Headpoint please visit www.headpointadvisors.com
(https://www.headpointadvisors.com/)
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRAEAFPKAFPLEFA